companydirectorylist.com  Global Business Directory e directory aziendali
Ricerca Società , Società , Industria :


elenchi dei paesi
USA Azienda Directories
Canada Business Elenchi
Australia Directories
Francia Impresa di elenchi
Italy Azienda Elenchi
Spagna Azienda Directories
Svizzera affari Elenchi
Austria Società Elenchi
Belgio Directories
Hong Kong Azienda Elenchi
Cina Business Elenchi
Taiwan Società Elenchi
Emirati Arabi Uniti Società Elenchi


settore Cataloghi
USA Industria Directories














  • Central Sleep Apnea (CSA) Treatment | remedē® System
    Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the rem edē System Rx only For further information, please visit remede zoll com, call +1-952-540-4470 or email info@remede zoll com
  • FDA approves Remedē implantable device to treat central sleep apnea
    Today the U S Food and Drug Administration announced the approval of the Remedē System, an implantable device for patients with central sleep apnea
  • remedē® System – P160039 | FDA
    The remedē System is an implanted nerve stimulator used to treat moderate to severe central sleep apnea (CSA) in adults
  • remedē System Patient Manual - Food and Drug Administration
    1 0 INTRODUCTION You and your doctor are considering the use of the remedē® System to treat your central sleep apnea (CSA) This guide is intended to inform you about CSA and the remedē System therapy
  • The remedē® System (for Central Sleep Apnea) - Deborah Heart Lung . . .
    Central sleep apnea (CSA) is a neurological condition that disrupts a person’s sleep because the brain does not send the correct signals to the breathing muscles during sleep CSA can lead to excessive daytime sleepiness, reduced exercise capacity, a decrease in blood oxygen levels, difficulty concentrating, and irregular or very fast heart rhythm For these patient, there is a new treatment
  • Implantable Devices for Sleep Apnea - St. Lukes
    Remede is an implantable system that sends regular signals to your diaphragm to help regulate your breathing, and can help patients who have moderate to severe CSA when other treatments aren't successful
  • 5-Year Study Confirms Safety, Efficacy, Beneficial Effects of Remedē . . .
    The peer-reviewed journal Nature and Science of Sleep has published five-year results from the remedē System Post Approval Study The data show sustained safety and efficacy of transvenous phrenic nerve stimulation for the treatment of moderate to severe central sleep apnea (CSA) The remedē System, the only implantable device approved by the US Food and Drug Administration (FDA) to treat
  • remedē® | Innovative treatment for Central Sleep Apnea
    The rem edē ® System is a breakthrough implantable system that safely and effectively treats moderate to severe central sleep apnea (CSA) in adult patients 3 CSA is a serious breathing disorder that disrupts the normal breathing pattern during sleep and has been shown to negatively impact quality of life and heart health 1 The latest advancement in rem edē System technology is now FDA




Annuari commerciali , directory aziendali
Annuari commerciali , directory aziendali copyright ©2005-2012 
disclaimer